The Second Domain of the CD45 Protein Tyrosine Phosphatase Is Critical for Interleukin-2 Secretion and Substrate Recruitment of TCR-ζ in Vivo*

  1. Nobuyuki Kashio,
  2. Wataru Matsumoto,
  3. Sirlester Parker and
  4. David M. Rothstein
  1. From the Department of Medicine, Yale Medical School, New Haven, Connecticut 06520

    Abstract

    The CD45 protein tyrosine phosphatase (PTPase) has been shown to regulate the activity of Lck and Fyn protein tyrosine kinases in T cells. However, it is not clear that these constitute the only CD45 substrates. Moreover, the manner by which PTPase activity and substrate recruitment are regulated, is poorly understood. Previousin vitro studies suggest that the first cytoplasmic PTPase domain (D1) of CD45 is the active PTPase, which may be regulated by an enzymatically inactive second PTPase domain (D2). However, the function of CD45 D2 in vivo is unknown. In this study, reconstitution of CD45 T cells with specific CD45 PTPase mutants allowed demonstration of a critical role for D2 in TCR-mediated interleukin (IL)-2 production. Specifically, replacement of CD45 D2 with that of the LAR PTPase to form a CD45/LAR:D2 chimera, abrogates CD45-dependent IL-2 production. This effect cannot be accounted for by loss of PTPase activity per se. The expression of D1 substrate-trapping mutants reveals an in vivo interaction between CD45 and TCR-ζ that is dependent on CD45 D2. Thus, cells expressing CD45 lacking D2 exhibit abnormal TCR-mediated signaling characterized by hyperphosphorylation of ζ and deficient ZAP-70 phosphorylation. These data suggest an essential role for CD45 D2 in TCR-regulated IL-2 production through substrate recruitment of the ζ chain.

    Footnotes

    • * This work was supported in part by National Institutes of Health Research Grant AI36317 and the American Cancer Society IM-779.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • To whom correspondence should be addressed: Internal Medicine/Nephrology, Yale Medical School, LCI 208, 333 Cedar St., New Haven, CT 06520. Tel.: 203-785-6738; Fax: 203-785-7068; E-mail:david.rothstein{at}yale.edu.

    • Abbreviations:
      PTPase

      protein tyrosine phosphatase

      CS

      Cys-to-Ser (replacement)

      D1

      first cytoplasmic phosphatase domain

      D2

      second cytoplasmic phosphatase domain

      PTK

      protein tyrosine kinase

      wt

      wild-type

      PAGE

      polyacrylamide gel electrophoresis

      IL-2

      interleukin-2

      mAb

      monoclonal antibody

      AEBSF

      aminoethylbenzenesulfonyl fluoride

      ITAM

      immunoreceptor tyrosine-based activation motif.

      • Received September 9, 1998.
    « Previous | Next Article »Table of Contents
    • Advertisement
    • Advertisement
    Advertisement